3D DNA double helix with a highlighted red DNA sequence representing genetic research and oligonucleotide synthesis.

Custom Oligonucleotide Synthesis Services: A Complete Guide for Researchers

BlogsLeave a comment

Oligonucleotides play an important role in modern molecular biology, pharmaceutical research, biotechnology, and molecular diagnostics. From amplifying specific DNA regions to analyzing gene expression and studying genetic variations, these short nucleic acid sequences support a wide range of laboratory applications. However, not every research experiment requires the same type of oligonucleotide. Sequence, length, purification, synthesis…

AI-Designed CRISPR Enables Hypoimmune iPSC Engineering for Off-the-Shelf Cell Therapy

Blogs

Induced pluripotent stem cells (iPSCs) are rapidly advancing regenerative medicine and cell therapy because they can differentiate into multiple human cell types. However, immune rejection remains a major barrier to developing scalable allogeneic cell therapies. In a recent webinar, Dr. Luke Ren from REPROCELL presented how the company is using StemEdit, its advanced gene editing…

Key Steps in Custom DNA Oligonucleotide Synthesis

Blogs

What Is Custom DNA Oligonucleotide Synthesis? Custom DNA oligonucleotide synthesis is the chemical process of building short, single-stranded DNA sequences—called oligonucleotides or “oligos”—in a controlled, laboratory setting. These synthetic DNA molecules are indispensable tools in modern molecular biology, genomics, diagnostics, and therapeutic development. Whether you are designing primers for PCR amplification, probes for next-generation sequencing…

Major Global News & Breakthroughs in Stem Cell Research

Blogs

Stem cell research has entered a decisive translational era. Breakthroughs in induced pluripotent stem cell (iPSC) technology and precision gene editing are rapidly converting experimental concepts into clinically validated therapies. What were once proof-of-concept studies are now progressing through late-stage clinical trials and, in some cases, delivering first-in-human successes. These advances are unlocking new therapeutic frontiers…

Myths About iPSCs: Top Misconceptions Debunked by Science

Blogs

Induced pluripotent stem cells (iPSCs) are among the most transformative innovations in modern regenerative medicine. The concept itself seems almost futuristic: by taking a small sample of somatic cells, such as skin fibroblasts, and reprogramming them back into a pluripotent state. These reprogrammed cells can give rise to diverse cell types, opening new possibilities for personalized medicine, disease modelling, and tissue regeneration.

Epigenetic Modifications: Their Role in iPSC Reprogramming and Differentiation

Blogs

Classic epigenetic modifications include DNA methylation and histone modifications as well as more broadly chromatin accessibility and non-coding RNAs. Epigenetic mechanisms enable heritable changes in gene expression that occur without altering the underlying DNA sequence. The various epigenetic layers act to control DNA accessibility and chromatin structure, which defines transcription factor binding and downstream gene…

Key Challenges in Clinical iPSC Applications: How REPROCELL Helps You Succeed

Blogs

1. Ethical and Regulatory Compliance The challenge: Clinical and commercial applications require strict ethical oversight and compliance with global regulatory standards. Our solution: REPROCELL follows IRB-approved informed consent protocols, and the clinical iPSC generation is compliant with all major regulatory standards (FDA, EMA, PMDA). We ensure: Full donor de-identification Ethical donor recruitment Global consent for clinical and…

Why mRNA Reprogramming Is the Key to Safer and Faster iPSC Generation?

Blogs

The Power of mRNA Reprogramming The emergence of mRNA reprogramming offers a precise, efficient, and xeno-free approach to generating induced pluripotent stem cells (iPSCs). These versatile cells hold immense potential for personalized medicine, disease modelling, and drug discovery. REPROCELL has led the way in mRNA reprogramming, in 2010 becoming the first company to commercialize mRNA-based…